Growing community of inventors

Beijing, China

Yinxiang Wang

Average Co-Inventor Count = 6.38

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Yinxiang WangWei Long (12 patents)Yinxiang WangYunyan Hu (8 patents)Yinxiang WangFenlai Tan (8 patents)Yinxiang WangShaojing Hu (7 patents)Yinxiang WangLieming Ding (7 patents)Yinxiang WangFei Wang (6 patents)Yinxiang WangYanping Wang (6 patents)Yinxiang WangCunbo Ma (5 patents)Yinxiang WangHong Cao (4 patents)Yinxiang WangXinshan Kang (4 patents)Yinxiang WangDon Zhang (3 patents)Yinxiang WangGuojian Xie (3 patents)Yinxiang WangXiaoyan Shen (3 patents)Yinxiang WangCharles Davis (3 patents)Yinxiang WangWei He (2 patents)Yinxiang WangYong Liu (2 patents)Yinxiang WangBin Han (2 patents)Yinxiang WangHaima Ai (2 patents)Yinxiang WangXiangdong Zhao (2 patents)Yinxiang WangFang Yu (1 patent)Yinxiang WangJianhua Han (1 patent)Yinxiang WangZhiguo Xu (1 patent)Yinxiang WangLiufeng Zhou (1 patent)Yinxiang WangJianxi Zhang (1 patent)Yinxiang WangZhengzhuang Cheng (1 patent)Yinxiang WangHang Chen (1 patent)Yinxiang WangMehrnaz Kamal (1 patent)Yinxiang WangFei Wang (0 patent)Yinxiang WangShujun Yuan (0 patent)Yinxiang WangHaima Al (0 patent)Yinxiang WangYinxiang Wang (15 patents)Wei LongWei Long (18 patents)Yunyan HuYunyan Hu (15 patents)Fenlai TanFenlai Tan (8 patents)Shaojing HuShaojing Hu (14 patents)Lieming DingLieming Ding (14 patents)Fei WangFei Wang (90 patents)Yanping WangYanping Wang (17 patents)Cunbo MaCunbo Ma (8 patents)Hong CaoHong Cao (10 patents)Xinshan KangXinshan Kang (6 patents)Don ZhangDon Zhang (16 patents)Guojian XieGuojian Xie (4 patents)Xiaoyan ShenXiaoyan Shen (3 patents)Charles DavisCharles Davis (3 patents)Wei HeWei He (115 patents)Yong LiuYong Liu (21 patents)Bin HanBin Han (13 patents)Haima AiHaima Ai (2 patents)Xiangdong ZhaoXiangdong Zhao (2 patents)Fang YuFang Yu (5 patents)Jianhua HanJianhua Han (2 patents)Zhiguo XuZhiguo Xu (2 patents)Liufeng ZhouLiufeng Zhou (2 patents)Jianxi ZhangJianxi Zhang (1 patent)Zhengzhuang ChengZhengzhuang Cheng (1 patent)Hang ChenHang Chen (1 patent)Mehrnaz KamalMehrnaz Kamal (1 patent)Fei WangFei Wang (0 patent)Shujun YuanShujun Yuan (0 patent)Haima AlHaima Al (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Betta Pharmaceuticals Co., Ltd. (8 from 19 patents)

2. Other (3 from 832,680 patents)

3. Beta Pharma, Inc. (3 from 16 patents)

4. Beijing Betta Pharmaceuticals Co., Ltd (2 from 2 patents)

5. Fujian Haixi Pharmaceuticals, Inc. (1 from 1 patent)

6. Betta Pharmacueticals Co., Ltd. (1 from 1 patent)

7. Kang, Xinshan (0 patent)


15 patents:

1. 9688687 - Polymorphic forms of icotinib phosphate and uses thereof

2. 9617257 - Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors

3. 9611272 - Polymorphic forms of icotinib and uses thereof

4. 9505774 - Polymorphic forms of icotinib maleate and uses thereof

5. 9487570 - Glucagon like peptide analogs, composition, and method of use

6. 9409900 - Compound for increasing kinase active and application thereof

7. 9359370 - Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof

8. 9242991 - Substituted fused heterocycles as c-Met tyrosine kinase inhibitors

9. 9238637 - Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof

10. 9206134 - Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof

11. 8951959 - Glucagon-like peptide-1 analogues and uses thereof

12. 8822482 - Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof

13. 8742138 - Compounds as hypoxia mimetics, and compositions and uses thereof

14. 7078409 - Fused quinazoline derivatives useful as tyrosine kinase inhibitors

15. 7030722 - High-temperature shutdown protecting relay

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…